9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

SU5416 in Treating Patients With Malignant Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > SU5416 in Treating Patients With Malignant Mesothelioma

SU5416 in Treating Patients With Malignant Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Mesothelioma

Estimated Enrollment: 45

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: ,  ,  ,

Interventions: semaxanib,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: February 2007

Completion Date: February 2009

Last  Posted Date: June 3, 2013

Location: University of Illinois at Chicago, Chicago, Illinois, United States

Website Link: https://ClinicalTrials.gov/show/NCT00006014

Was this article helpful?
Dislike 0